Your browser doesn't support javascript.
loading
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
Labaki, Wassim W; Gu, Tian; Murray, Susan; Curtis, Jeffrey L; Wells, J Michael; Bhatt, Surya P; Bon, Jessica; Diaz, Alejandro A; Hersh, Craig P; Wan, Emily S; Kim, Victor; Beaty, Terri H; Hokanson, John E; Bowler, Russell P; Arenberg, Douglas A; Kazerooni, Ella A; Martinez, Fernando J; Silverman, Edwin K; Crapo, James D; Make, Barry J; Regan, Elizabeth A; Han, MeiLan K.
Afiliación
  • Labaki WW; Division of Pulmonary and Critical Care Medicine.
  • Gu T; Department of Biostatistics, T.H. Chan School of Public Health.
  • Murray S; Department of Biostatistics, and.
  • Curtis JL; Division of Pulmonary and Critical Care Medicine.
  • Wells JM; Medical Service, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
  • Bhatt SP; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Bon J; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Diaz AA; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Hersh CP; Medical Service, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
  • Wan ES; Division of Pulmonary and Critical Care Medicine, and.
  • Kim V; Division of Pulmonary and Critical Care Medicine, and.
  • Beaty TH; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts.
  • Hokanson JE; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts.
  • Bowler RP; Veterans Affairs Boston Healthcare System, Boston, Massachusetts.
  • Arenberg DA; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
  • Kazerooni EA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Martinez FJ; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Silverman EK; Division of Pulmonary, Critical Care and Sleep Medicine and.
  • Crapo JD; Division of Pulmonary and Critical Care Medicine.
  • Make BJ; Division of Pulmonary and Critical Care Medicine.
  • Regan EA; Department of Radiology, University of Michigan, Ann Arbor, Michigan.
  • Han MK; Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, New York.
Am J Respir Crit Care Med ; 208(4): 451-460, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37159910
ABSTRACT
Rationale Cigarette smoking contributes to the risk of death through different mechanisms.

Objectives:

To determine how causes of and clinical features associated with death vary in tobacco cigarette users by lung function impairment.

Methods:

We stratified current and former tobacco cigarette users enrolled in Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) into normal spirometry, PRISm (Preserved Ratio Impaired Spirometry), Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1-2 COPD, and GOLD 3-4 COPD. Deaths were identified via longitudinal follow-up and Social Security Death Index search. Causes of death were adjudicated after a review of death certificates, medical records, and next-of-kin interviews. We tested associations between baseline clinical variables and all-cause mortality using multivariable Cox proportional hazards models. Measurements and Main

Results:

Over a 10.1-year median follow-up, 2,200 deaths occurred among 10,132 participants (age 59.5 ± 9.0 yr; 46.6% women). Death from cardiovascular disease was most frequent in PRISm (31% of deaths). Lung cancer deaths were most frequent in GOLD 1-2 (18% of deaths vs. 9-11% in other groups). Respiratory deaths outpaced competing causes of death in GOLD 3-4, particularly when BODE index ⩾7. St. George's Respiratory Questionnaire score ⩾25 was associated with higher mortality in all groups Hazard ratio (HR), 1.48 (1.20-1.84) normal spirometry; HR, 1.40 (1.05-1.87) PRISm; HR, 1.80 (1.49-2.17) GOLD 1-2; HR, 1.65 (1.26-2.17) GOLD 3-4. History of respiratory exacerbations was associated with higher mortality in GOLD 1-2 and GOLD 3-4, quantitative emphysema in GOLD 1-2, and airway wall thickness in PRISm and GOLD 3-4.

Conclusions:

Leading causes of death vary by lung function impairment in tobacco cigarette users. Worse respiratory-related quality of life is associated with all-cause mortality regardless of lung function.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Productos de Tabaco Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Productos de Tabaco Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article